Acadian Asset Management
BCRX icon

Acadian Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Acadian Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
180,010
+94,710
+111% +$736K ﹤0.01% 1006
2025
Q4 		$662K Sell
85,300
-754,103
-90% -$5.45M ﹤0.01% 1226
2025
Q3 		$6.36M Buy
839,403
+467,631
+126% +$3.89M 0.01% 575
2025
Q2 		$3.33M Sell
371,772
-298,589
-45% -$2.78M 0.01% 690
2025
Q1 		$5.02M Buy
670,361
+475,564
+244% +$3.84M 0.01% 497
2024
Q4 		$1.46M Buy
194,797
+183,472
+1,620% +$1.39M ﹤0.01% 846
2024
Q3 		$85K Buy
+11,325
New +$86.1K ﹤0.01% 1644
2020
Q3 		– Sell
-15,932
Closed -$76K – 2170
2020
Q2 		$76K Sell
15,932
-175,832
-92% -$702K ﹤0.01% 1790
2020
Q1 		$383K Buy
+191,764
New +$528K ﹤0.01% 1031

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return